BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will host a conference call and live audio webcast on March 11, 2015, at 8:30 a.m. ET to report fourth quarter and year-end 2014 financial results.
Help employers find you! Check out all the jobs and post your resume.
